• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Role of the FDG PET CT Scan in Pretreatment Evaluation of Oral Carcinomas.FDG PET CT扫描在口腔癌术前评估中的作用
Indian J Otolaryngol Head Neck Surg. 2024 Dec;76(6):5346-5352. doi: 10.1007/s12070-024-04974-4. Epub 2024 Aug 24.
2
The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)在结直肠癌术前分期中的价值:系统评价和经济评估。
Health Technol Assess. 2011 Sep;15(35):1-192, iii-iv. doi: 10.3310/hta15350.
3
Thoracic imaging tests for the diagnosis of COVID-19.用于 COVID-19 诊断的胸部影像学检查。
Cochrane Database Syst Rev. 2022 May 16;5(5):CD013639. doi: 10.1002/14651858.CD013639.pub5.
4
Role of Metabolic Parameters of 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (18F-FDG PET-CT) Imaging in Predicting Progression-Free Survival of Radioiodine-Refractory Differentiated Thyroid Cancer: A Single-Center Study.18F-氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描(18F-FDG PET-CT)成像的代谢参数在预测放射性碘难治性分化型甲状腺癌无进展生存期方面的作用:一项单中心研究
Cureus. 2025 May 28;17(5):e84998. doi: 10.7759/cureus.84998. eCollection 2025 May.
5
Assessing the Potential Usefulness of FDG LAFOV-PET for Oncological Staging: An Evaluation of Lesion Number and Uptake.评估18F-FDG大视野PET在肿瘤分期中的潜在应用价值:病变数量及摄取情况评估
Cancers (Basel). 2025 Jun 10;17(12):1927. doi: 10.3390/cancers17121927.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
8
Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses.术中冰冻切片分析用于诊断可疑盆腔肿块中的早期卵巢癌。
Cochrane Database Syst Rev. 2016 Mar 1;3(3):CD010360. doi: 10.1002/14651858.CD010360.pub2.
9
Is 18 F-fluoride PET/CT an Accurate Tool to Diagnose Loosening After Total Joint Arthroplasty?18F-氟化物PET/CT是诊断全关节置换术后假体松动的准确工具吗?
Clin Orthop Relat Res. 2025 Mar 1;483(3):415-428. doi: 10.1097/CORR.0000000000003228. Epub 2024 Sep 11.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

本文引用的文献

1
SUV values at FDG PET-CT to predict malignancy in lymph nodes aspirated by real time image fused USgFNAC in head and neck squamous cell carcinoma.利用18F-氟脱氧葡萄糖正电子发射断层显像-计算机断层扫描(FDG PET-CT)的标准化摄取值(SUV)预测头颈部鳞状细胞癌中经实时图像融合超声引导下细针穿刺抽吸活检(USgFNAC)的淋巴结是否为恶性。
Am J Nucl Med Mol Imaging. 2021 Jun 15;11(3):178-187. eCollection 2021.
2
FDG-PET-CT/MRI in head and neck squamous cell carcinoma: Impact on pretherapeutic N classification, detection of distant metastases, and second primary tumors.头颈部鳞状细胞癌的 FDG-PET-CT/MRI:对治疗前 N 分期、远处转移和第二原发肿瘤的影响。
Head Neck. 2021 Jul;43(7):2058-2068. doi: 10.1002/hed.26668. Epub 2021 Mar 17.
3
Accuracy of F-FDG PET/CT in Detection of Neck Metastases of Oral Squamous Cell Carcinoma in Patients Without Large Palpable Lymph Nodes.18F-FDG PET/CT 对无明显可触及淋巴结的口腔鳞癌颈部转移的诊断准确性。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Apr;129(4):418-426. doi: 10.1016/j.oooo.2019.09.005. Epub 2019 Oct 2.
4
F-FDG PET/CT versus CT/MR imaging for detection of neck lymph node metastasis in palpably node-negative oral cavity cancer.18F-FDG PET/CT 与 CT/MR 成像在触诊阴性口腔癌颈部淋巴结转移中的应用比较。
J Cancer Res Clin Oncol. 2020 Jan;146(1):237-244. doi: 10.1007/s00432-019-03054-3. Epub 2019 Oct 12.
5
Oral Cancer.口腔癌。
Aust Dent J. 2018 Mar;63 Suppl 1:S91-S99. doi: 10.1111/adj.12594.
6
The Role of PET-CT in Evaluation of Cervical Lymph Node Metastases in Oral Cavity Squamous Cell Carcinomas.PET-CT在口腔鳞状细胞癌颈淋巴结转移评估中的作用
Turk Arch Otorhinolaryngol. 2015 Jun;53(2):67-72. doi: 10.5152/tao.2015.608. Epub 2015 Jun 1.
7
Oral cancer: Etiology and risk factors: A review.口腔癌:病因与风险因素:综述
J Cancer Res Ther. 2016 Apr-Jun;12(2):458-63. doi: 10.4103/0973-1482.186696.
8
Cancer of the oral cavity.口腔癌
Surg Oncol Clin N Am. 2015 Jul;24(3):491-508. doi: 10.1016/j.soc.2015.03.006. Epub 2015 Apr 15.
9
Oral cancer in India continues in epidemic proportions: evidence base and policy initiatives.印度的口腔癌仍呈流行趋势:循证基础和政策举措。
Int Dent J. 2013 Feb;63(1):12-25. doi: 10.1111/j.1875-595x.2012.00131.x. Epub 2012 Dec 13.
10
Challenges of the oral cancer burden in India.印度口腔癌负担面临的挑战。
J Cancer Epidemiol. 2012;2012:701932. doi: 10.1155/2012/701932. Epub 2012 Oct 4.

FDG PET CT扫描在口腔癌术前评估中的作用

Role of the FDG PET CT Scan in Pretreatment Evaluation of Oral Carcinomas.

作者信息

Banjare Amit Kumar, Arora Ripu Daman, Ravina Mudalsha, Prajwal S D, Rao Karthik Nagaraja, Nagarkar Nitin M

机构信息

Department of Otolaryngology and Head Neck Surgery, All India Institute of Medical Sciences, Raipur, Raipur, Chhattisgarh India.

Department of Nuclear Medicine, All India Institute of Medical Sciences, Raipur, Raipur, Chhattisgarh India.

出版信息

Indian J Otolaryngol Head Neck Surg. 2024 Dec;76(6):5346-5352. doi: 10.1007/s12070-024-04974-4. Epub 2024 Aug 24.

DOI:10.1007/s12070-024-04974-4
PMID:39559068
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11569347/
Abstract

Pre-treatment role of FDG PET CT scan to evaluate- the extent of the primary lesion, nodal staging and distant metastasis in oral carcinoma in various TNM stages. Additionally, our study investigated the Correlation between SUVmax values on FDG-PET CT scans and histopathological proven positive nodes in patients undergoing surgery. In this study, all suspected cases of oral carcinoma in adults who visited the ENT clinic were examined and evaluated using various methods, including clinical examination, cytology, histopathology, and imaging tests like CECT scans, ultrasound, and CEMRI. Based on the results of these evaluations, the patients were staged. The patients were then given FDG-PET CT scans (done within 2 weeks of CECT/MRI scans), for restaging and treatment plans, such as surgery, chemotherapy, radiotherapy, or a combination of these methods, were developed. After surgery, the patients were restaged based on the histopathology report, and the results of the FDG-PET CT scans were compared to the histopathological findings and the histopathological positive nodes were compared to the SUV max value on the FDG PET CT scan and were correlated. In our study, the mean age of patients was found to be 50 years with a male: female ratio of 3.5:1. Maximum tumors presented at the buccal mucosa region. 92% of patients gave a history of tobacco addiction, and 18% were smokers. As per initial biopsy reports, maximum (62%) tumors were detected to be WDSCC, 2% were MDSCC and 6% were PDSCC. All 50 patients had normal findings on the chest x-ray and USG abdomen. 41 patients underwent CECT scans and 9 patients got CEMRI scans done. Staging after FDG PET CT scan was compared with that of radiological staging. It was found that in T staging there was upstaging in 36% of cases and downstaging in 14% of cases following the FDG PET CT scan. Likewise, N staging showed upstaging in 36% of cases and downstaging in 16% of cases after the FDG PET CT scan. In M staging, there was upstaging in 10% of cases after the FDG PET CT scan. In our study 15 cases got operated on. All 8 (53.3%) cases of postoperative histopathological positive lymph nodes had SUV max values greater than their reference value (> 2.5), and all negative histopathological lymph nodes had a low SUV max (< 2.5) value in the PET CT scan. The FDG PET CT scan is a highly effective tool for accurately diagnosing, staging, and predicting the outcome of oral cancers at all stages of the disease. The SUV max value (> 2.5) of the PET CT scan is positively correlated with the likelihood of nodal metastasis, as higher values were found to correspond with histopathological evidence of positive neck nodes.

摘要

氟代脱氧葡萄糖正电子发射断层扫描计算机断层扫描(FDG PET CT)在评估口腔癌不同TNM分期中原发病灶范围、淋巴结分期及远处转移方面的治疗前作用。此外,我们的研究调查了接受手术患者的FDG - PET CT扫描中最大标准摄取值(SUVmax)与组织病理学证实的阳性淋巴结之间的相关性。在本研究中,对所有就诊于耳鼻喉科诊所的成年口腔癌疑似病例采用多种方法进行检查和评估,包括临床检查、细胞学检查、组织病理学检查以及诸如增强CT扫描(CECT)、超声和磁共振成像(CEMRI)等影像学检查。根据这些评估结果对患者进行分期。然后对患者进行FDG - PET CT扫描(在CECT/MRI扫描后2周内完成),用于重新分期并制定治疗方案,如手术、化疗、放疗或这些方法的联合应用。手术后,根据组织病理学报告对患者重新分期,并将FDG - PET CT扫描结果与组织病理学结果进行比较,将组织病理学阳性淋巴结与FDG PET CT扫描上的SUV max值进行比较并分析相关性。在我们的研究中,患者的平均年龄为50岁,男女比例为3.5:1。最大肿瘤出现在颊黏膜区域。92%的患者有吸烟史,18%为吸烟者。根据初始活检报告,最大比例(62%)的肿瘤为高分化鳞状细胞癌(WDSCC),2%为中分化鳞状细胞癌(MDSCC),6%为低分化鳞状细胞癌(PDSCC)。所有50例患者胸部X线和腹部超声检查结果均正常。41例患者接受了CECT扫描,9例患者进行了CEMRI扫描。将FDG PET CT扫描后的分期与放射学分期进行比较。结果发现,在T分期中,FDG PET CT扫描后36%的病例分期上调,14%的病例分期下调。同样,在N分期中,FDG PET CT扫描后36%的病例分期上调,16%的病例分期下调。在M分期中,FDG PET CT扫描后10%的病例分期上调。在我们的研究中,15例患者接受了手术。术后组织病理学阳性淋巴结的所有8例(53.3%)病例的SUV max值均大于其参考值(> 2.5),而组织病理学阴性淋巴结在PET CT扫描中的SUV max值均较低(< 2.5)。FDG PET CT扫描是一种在口腔癌疾病的所有阶段准确诊断、分期和预测预后的高效工具。PET CT扫描的SUV max值(> 2.5)与淋巴结转移的可能性呈正相关,因为较高的值与颈部阳性淋巴结的组织病理学证据相对应。